Industry News
Disrupting interactions sends Progen's stocks sky-high
The share price of Queensland biotech company Progen Industries has almost tripled in less than six months following promising Phase II clinical trial results for its lead cancer compound and the expectation of more good news in the near future. [ + ]
BIO profile: Top down carbohydrate chemistry
Fucoidans are a family of polysaccharides that can act, amongst other things, as immunomodulators, selectin antagonists, viral attachment inhibitors and receptor blockers. And they are sourced directly from seaweed. [ + ]
Minority groups not genetically prone to diabetes
A study by Australian and US researchers is helping dispel the 40-year-old ‘thrifty genotype theory’ – that certain minority groups are genetically prone to diabetes.
[ + ]BIO profile: Hit and hit again for Bionomics
Bionomics has some good news to take to BIO 2007 from preclinical trials of its candidate vascular disruption agent. [ + ]
Genetic 'Gang of Four' drives spread of breast cancer
Studies of human tumour cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs. [ + ]
Panel chairs named for RQF
The federal government has appointed the chairs of the 13 assessment panels being established under the controversial research quality framework (RQF) system. [ + ]
UQ uses nanotechnology in medical testing
University of Queensland researchers are using nanotechnology in the medical diagnostic testing of diseases such as cervical cancer.
[ + ]BIO profile: The hope beyond the hype
The CSIRO is sponsoring a session on biomaterials and regenerative medicine at BIO2007. Kate McDonald spoke to CSIRO's theme leader for the area, Keith McLean, about this competitive but challenging field. [ + ]
Technology reveals 'lock and key' proteins behind diseases
Canadian researchers have developed a new technology to reveal the biochemical processes responsible for diseases such as cystic fibrosis. [ + ]
BIO profile: Beta agonists for metabolic modification
West Australian animal health company Stirling Products is developing a compound for increased muscle production and reduced fat in livestock that also has applications in porky pets. [ + ]
Fragile X, Down syndromes linked to faulty brain communication
Mosaic mouse model allows neuroscientists to see how Fragile X and Down syndromes cause problems in the neural network. [ + ]
Tackling skin cancer in organ transplant patients
Clinuvel Pharmaceuticals is heading into further Phase II and beginning Phase III trials for several UV-related indications for its photo-protective drug CUV1647. The big hope, however, is its potential to protect organ transplant recipients. [ + ]
League greats tackle melanoma research
The University of Queensland (UQ) has received a $48,000 donation to its cancer research institute from cancer charity group, Mardi Jackson Foundation.
[ + ]Chemeq thrown a lifeline
A private financier may have come to the rescue of embattled animal health company Chemeq. [ + ]
Dogs do the legwork for human cancer prevention
700 Rottweilers will assist American researchers to discover whether antioxidant supplementation has a preventative effect in bone cancer. [ + ]